RAD51 and non-small cell lung carcinoma: Previous studies have shown that emodin reduces the mRNA and protein stability of RAD51 in NSCLC, influencing genes related to apoptosis, tumor metastasis, and chemotherapy resistance, ultimately leading to cell apoptosis 42.